Heart Failure Food Intervention Trial: Impact of a Guideline-based Nutrition Digital Tool in Heart Failure Patient Clinical Outcomes
HF-FIT
2 other identifiers
interventional
180
1 country
1
Brief Summary
Measuring the impact of a guideline-based nutrition digital tool in heart failure patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2025
CompletedFirst Submitted
Initial submission to the registry
May 14, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 31, 2025
May 1, 2025
1.5 years
May 14, 2025
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure
Blood pleasure will be measure by mmHg
Baseline and 6 months
Secondary Outcomes (1)
Weight
Baseline and 6 months
Study Arms (3)
Control
NO INTERVENTIONPatients in the control arm will be asked to complete a baseline survey questionnaire and a final survey questionnaire 6 months after they enroll. During enrollment or (if not obtained at baseline) up to 1 month after, patients will be asked to provide their baseline BP and weight measurements. Study team members will contact patients at month 3 and 6 to ask how they are doing and get follow up BP and weight measurements.
Intervention: MedChefs
EXPERIMENTALOnce patients have been randomized to the MedChefs arm, they will be contacted by the research team and sent an email link to use the MedChefs app During enrollment or up to 1 month after, patients will be contacted to provide their baseline BP and weight measurements. Patients will be contacted at month 3 and 6 by the research team to see how they are doing, about their app use, get their BP and weight measurements and will be sent a final survey 6 months after they first log into MedChefs.
MedChefs plus Instacart Food Voucher
EXPERIMENTALOnce patients have been randomized to the MedChefs arm and voucher arm, they will be contacted by the research team and sent an email link to use the MedChefs app. Patients will also be given a $100 voucher to buy food recommended by the app. Vouchers will be provided once a month for the 6 months of the study. During enrollment or up to 1 month after, patients will be asked to provide their baseline BP and weight measurements. At month 3 and 6 the research team will contact the patients to see how they are doing and ask for patients follow up BP and weight measurements. Patients will also be asked to complete a final survey 6 months after they first log into MedChefs.
Interventions
Once patients have been randomized to the MedChefs arm, they will be contacted by the research team and sent an email link to use the MedChefs app. The research team will contact the patient based on their preferred contact method and will walk through how to use the app and share education on its use.
Once patients have been randomized to the MedChefs arm and voucher arm, they will be contacted by the research team and sent an email link to use the MedChefs app. The research team will contact the patient based on their preferred contact method and will walk through how to use the app and share education on its use and use of Instacart food vouchers. Patients will also be given a $100 voucher to buy food recommended by the app. Vouchers will be provided once a month for the 6 months of the study
Eligibility Criteria
You may qualify if:
- years old at time of enrollment
- Any type of Heart failure diagnosis (e.g., I50.x) between 1/1/2023-present
- Recent hospital admission (within a year)
- Race/ethnicity: All race/ethnic groups
- Location: patients have been treated in the Greater East Bay division and Greater Silicon Valley division areas.
- Patients with have at least 1 office/outpatient visit with a primary care physician or cardiologist visit before index date
You may not qualify if:
- Patients with certain patient history (cognitive disabilities) and end stage renal or metastatic cancer diagnosis
- Patients with active drug/substance use. Patients with heart failure who have active substance use are excluded from the study. HF patients with substance use require additional monitoring and follow up due to potential severe withdrawal symptoms, acute HF exacerbation and drug overdose or medication errors. Standard protocol includes additional monitor vital signs (e.g., blood pressure, heart rate) and HF symptoms (e.g., edema, dyspnea), and performing regular laboratory tests (e.g., renal function, electrolytes) which is beyond the clinical and logistical capabilities of this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sutter Healthlead
Study Sites (1)
2121 N. California Blvd., Suite 310
Walnut Creek, California, 94596, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2025
First Posted
May 31, 2025
Study Start
February 25, 2025
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 31, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share